A novel human parainfluenza virus type 1 (HPIV1) with separated P and C genes is useful for generating C gene mutants for evaluation as live-attenuated virus vaccine candidates.
about
Progress in the development of human parainfluenza virus vaccinesAttenuated Human Parainfluenza Virus Type 1 (HPIV1) Expressing the Fusion Glycoprotein of Human Respiratory Syncytial Virus (RSV) as a Bivalent HPIV1/RSV Vaccine.Human parainfluenza virus serotypes differ in their kinetics of replication and cytokine secretion in human tracheobronchial airway epithelium.
P2860
A novel human parainfluenza virus type 1 (HPIV1) with separated P and C genes is useful for generating C gene mutants for evaluation as live-attenuated virus vaccine candidates.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A novel human parainfluenza vi ...... ated virus vaccine candidates.
@en
A novel human parainfluenza virus type 1
@nl
type
label
A novel human parainfluenza vi ...... ated virus vaccine candidates.
@en
A novel human parainfluenza virus type 1
@nl
prefLabel
A novel human parainfluenza vi ...... ated virus vaccine candidates.
@en
A novel human parainfluenza virus type 1
@nl
P2093
P2860
P1433
P1476
A novel human parainfluenza vi ...... ated virus vaccine candidates.
@en
P2093
Adam Castaño
Alexander C Schmidt
Ann-Marie Cruz
Brian R Murphy
Emmalene J Bartlett
Janice Esker
Jim Boonyaratanakornkit
Mario H Skiadopoulos
Peter L Collins
P2860
P304
P356
10.1016/J.VACCINE.2009.10.069
P407
P577
2009-10-24T00:00:00Z